Nigro N D, Seydel H G, Considine B, Vaitkevicius V K, Leichman L, Kinzie J J
Cancer. 1983 May 15;51(10):1826-9. doi: 10.1002/1097-0142(19830515)51:10<1826::aid-cncr2820511012>3.0.co;2-l.
Twenty-eight patients with squamous cell carcinoma of the anal canal were treated by preoperative radiation therapy and chemotherapy. The radiation therapy was given for 3000 rad (30 Gy) at 200 rad per day, 5 days a week, to the primary tumor with margin and to the pelvic and inguinal lymph nodes. Chemotherapy was given in the form of 5-fluorouracil infusion 1000 mg/m2 on days 1-4 of the radiation therapy and repeated on days 29-32 of the treatment regimen. Mitomycin C was given in the form of intravenous bolus for 15 mg/m2 on day 1. Surgery was done 4-6 weeks following the last day of radiation treatment. Twelve patients underwent anteroposterior resection, and seven of the 12 had no residual tumor in the surgical specimen, while one patient had microscopic tumor only. An additional 14 patients had complete clinical disappearance of their tumor, and, on excision of the scar, it was found free of microscopic cancer. Two other patients are clinically free of tumor but had no biopsy after therapy. While transient proctitis leukopenia and thrombocytopenia were moderate to severe, no serious complications were observed in these patients. Twenty-two patients are free of tumor and alive one to eight years after treatment. One patient died a cardiac death without tumor four years after surgery. Four patients, all with residual tumor in the specimen, have died of cancer. Their primary lesions were more than 7 cm in maximum diameter at initial examination. One patient died of disseminated disease with no local recurrence after abdominal perineal resection.
28例肛管鳞状细胞癌患者接受了术前放疗和化疗。放疗采用每天200拉德(2戈瑞),每周5天,对原发肿瘤及其边缘、盆腔和腹股沟淋巴结给予3000拉德(30戈瑞)的剂量。化疗采用在放疗第1 - 4天静脉输注5 - 氟尿嘧啶1000毫克/平方米,并在治疗方案的第29 - 32天重复。丝裂霉素C在第1天以静脉推注的形式给予,剂量为15毫克/平方米。放疗最后一天后4 - 6周进行手术。12例患者接受了前后位切除术,其中12例中有7例手术标本中无残留肿瘤,1例仅存在微小肿瘤。另外14例患者肿瘤临床完全消失,切除瘢痕后发现无微小癌。另外2例患者临床无肿瘤,但治疗后未进行活检。虽然短暂性直肠炎、白细胞减少和血小板减少为中度至重度,但这些患者未观察到严重并发症。22例患者治疗后无肿瘤存活1至8年。1例患者术后4年因心脏原因死亡,无肿瘤。4例患者标本中均有残留肿瘤,均死于癌症。他们的原发病变在初诊时最大直径超过7厘米。1例患者经腹会阴切除术后死于播散性疾病,无局部复发。